A phase II study of neoadjuvant chemotherapy using combined taxane, anthracycline, and cyclophosphamide in high risk HER2-negative locally advanced breast cancer ; A phase 2 study of neoadjuvant chemotherapy using combined taxane, anthracycline, and cyclophosphamide in high risk HER2-negative locally advanced breast cancer

Published in 2015 by Wyj Chiu, Rcy Leung, Tkd Suen, Thc Chen, Cyl Chow, G. Kwok, H. Wong, P. Cheung, Tcc Yau, A. Kwong

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload

Oral Presentation